Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
Status:
Completed
Trial end date:
2012-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this six month study is to show that dutasteride is safe and more effective
than placebo, and at least as safe and effective as finasteride in treating hair loss in men
with androgenetic alopecia. Three doses of dutasteride will be investigated.